RYTM — Rhythm Pharmaceuticals, Inc. stock price, charts and financials

QT43Rhythm Pharmaceuticals, Inc.

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
105.78
+3.00+2.92%
OverviewShort InterestFilings
RYTMQT43Rhythm Pharmaceuticals, Inc.·NASDAQ
105.78+2.92%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Jul 02, 20264Statement of changes in beneficial ownership
Jun 25, 20264Statement of changes in beneficial ownership
Jun 25, 20264Statement of changes in beneficial ownership
Jun 25, 20264Statement of changes in beneficial ownership
Jun 25, 20264Statement of changes in beneficial ownership
Jun 25, 20268-KCurrent report
Jun 25, 20264Statement of changes in beneficial ownership
Jun 24, 20264Statement of changes in beneficial ownership
Jun 15, 20268-KCurrent report
May 29, 2026DEFA14AAdditional proxy soliciting materials
May 20, 20264Statement of changes in beneficial ownership
May 19, 20264Statement of changes in beneficial ownership
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 05, 2026S-8Registration of employee benefit securities
May 05, 202610-QQuarterly report
May 05, 2026DEFA14AAdditional proxy soliciting materials
May 05, 20268-KCurrent report
Apr 30, 2026SC 13GBeneficial ownership statement (passive)
Apr 29, 2026DEF 14ADefinitive proxy statement
Apr 29, 2026ARSAnnual report to shareholders
Apr 03, 20263Initial statement of beneficial ownership
Apr 03, 20264Statement of changes in beneficial ownership
Apr 03, 20268-KCurrent report
Apr 03, 20264Statement of changes in beneficial ownership
Mar 27, 2026SC 13G/ABeneficial ownership statement (passive, amended)
#1 / 25 of 415
Page
▼
/ 17